SPC278
daratumumab, bortezomib og dexamethasone
Status:
UmsóknApplication date:
9.10.2019Application published:
15.11.2019
Max expiry date:
2.5.2032Medicine name:
DarzalexMedicine for children:
No
Timeline
Today
9.10.2019Application
15.11.2019Publication
2.5.2032Expires
Marketing license
Foreign authorization number:
EU/1/16/1101Date:
28.4.2017
Owner
Name:
Genmab A/SAddress:
Carl Jacobsens Vej 30, Valby DK
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128 Reykjavík
Patent
Number:
EP2081595